Open AccessPregnancy rates among female participants in phase 1 and phase 2A AIDS vaccine clinical trials in Kenya
Author(s) -
Walter Jaoko,
H Ogutu,
Sabina Wakasiaka,
R Malogo,
R Ndambuki,
J Nyange,
Gloria Omosa-Manyonyi,
Patricia E. Fast,
Claudia Schmidt,
Carl Verlinde,
Carol Smith,
Bhatt Km,
JO Ndinya–Achola,
Omu Anzala
Publication year - 2010
Publication title -
east african medical journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.102
H-Index - 40
ISSN - 0012-835X
DOI - 10.4314/eamj.v86i9.54165
Subject(s) - medicine , abstinence , family planning , sexual abstinence , clinical trial , observational study , pregnancy , family medicine , fertility , population , gynecology , obstetrics , demography , environmental health , psychiatry , research methodology , biology , genetics , sociology
Female participants in AIDS candidate vaccine clinical trials must agree to use effective contraception to be enrolled into the studies, and for a specified period after vaccination, since the candidate vaccines' effects on the embryo or foetus are unknown.